A detailed history of Federated Hermes, Inc. transactions in Arbutus Biopharma Corp stock. As of the latest transaction made, Federated Hermes, Inc. holds 3 shares of ABUS stock, worth $9. This represents 0.0% of its overall portfolio holdings.

Number of Shares
3
Holding current value
$9
% of portfolio
0.0%

Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$3.12 - $4.56 $9 - $13
3 New
3 $0
Q1 2024

May 14, 2024

BUY
$2.26 - $2.92 $24,934 - $32,216
11,033 New
11,033 $28,000
Q4 2021

Feb 14, 2022

SELL
$3.11 - $4.61 $1,925 - $2,853
-619 Closed
0 $0
Q3 2021

Nov 15, 2021

SELL
$2.65 - $4.62 $1,362 - $2,374
-514 Reduced 45.37%
619 $3,000
Q2 2021

Aug 16, 2021

BUY
$2.5 - $3.51 $342 - $480
137 Added 13.76%
1,133 $3,000
Q1 2021

May 13, 2021

BUY
$3.14 - $4.84 $1,359 - $2,095
433 Added 76.91%
996 $3,000
Q3 2018

Nov 13, 2018

BUY
$7.85 - $12.35 $78 - $123
10 Added 1.81%
563 $5,000
Q2 2018

Aug 10, 2018

BUY
$5.0 - $7.35 $2,765 - $4,064
553 New
553 $4,000

Others Institutions Holding ABUS

About Arbutus Biopharma Corp


  • Ticker ABUS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 149,951,008
  • Market Cap $477M
  • Description
  • Arbutus Biopharma Corporation, a biopharmaceutical company, develops novel therapeutics for chronic Hepatitis B virus (HBV) infection, SARS-CoV-2, and other coronaviruses in the United States. Its HBV product pipeline consists of AB-729, a proprietary subcutaneously delivered RNA interference product candidate, which in Phase Ia/Ib clinical tria...
More about ABUS
Track This Portfolio

Track Federated Hermes, Inc. Portfolio

Follow Federated Hermes, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Federated Hermes, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Federated Hermes, Inc. with notifications on news.